Related Experiment Video
Updated: Apr 30, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
27.4K
SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study
Jon C George1, Eric S Rosen1, Jonathan Nachtigall1
1Division of Interventional Cardiology & Endovascular Medicine, Deborah Heart and Lung Center, 200 Trenton Road, Browns Mills, NJ 08015.
Journal of Vascular and Interventional Radiology : JVIR
|April 29, 2014
Summary
The interwoven nitinol SUPERA stent shows promising results for treating severe superficial femoral and popliteal artery disease. It demonstrated high patency rates and improved blood flow, offering a viable treatment option.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Background:
- Superficial femoral and popliteal artery disease significantly impacts patient mobility.
- Current treatment options may have limitations for complex lesions.
Purpose of the Study:
- To evaluate the safety and efficacy of the novel interwoven-wire self-expanding nitinol SUPERA stent.
- To assess outcomes in patients with severe femoropopliteal arterial disease.
Main Methods:
- Retrospective analysis of 80 patients (98 limbs) treated with SUPERA stents.
- Follow-up averaged 14.3 months, assessing patency and clinical outcomes.
Main Results:
- High primary patency rates: 96.9% at 6 months and 85.8% at 12 months.
- Significant improvement in ankle-brachial index (0.60 to 0.83, P < .001).
- No stent fractures observed in limbs requiring reintervention.
Conclusions:
- The interwoven nitinol stent design is a viable option for high-grade femoropopliteal obstructive disease.
- This novel stent demonstrates favorable patency and clinical outcomes in a single-center experience.
